# Pivotal bioVenture Partners: portfolio, investments and team > Pivotal bioVenture Partners is a vc firm based in United States. 11 investments on record, 1 in the last 12 months, latest Jul 2026. Source: https://millionrounds.com/fund/pivotal-life-sciences (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Pivotal bioVenture Partners Last cheque observed Jul 2026; 11 cheques on record. Deploying now New fund $1.1M, Aug 2021 VC firm Series B Series A Series C Life Sciences Therapeutics Healthcare Deploying now **100%** of best year **1** **cheques in 12 months**, 11 on record Since the last cheque **95** days **00** hrs **00** min **00** sec Median round **$80M** Rounds led **2 of 11** Sole investor **1 rounds** Mostly in **United States, 70%** Pitch Pivotal bioVenture Partners ## Pivotal bioVenture Partners highlights - 01 1 cheques in the last 12 months - 02 Mostly Series B and Series A: 82% of its rounds - 03 Sole investor in 1 rounds, median $54M ## What they do > we are a life sciences venture capital firm investing in transformative therapeutic-focused healthcare companies across North America and Europe. From their own website - **Type:** VC firm - **Cheque size:** Not stated - **Sectors:** Life Sciences Therapeutics Healthcare - **Based in:** San Francisco, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **11 appearances** - **2026** 1 round - **Jul** **[Crystalys Therapeutics](https://millionrounds.com/company/crystalys-therapeutics)** Series B · Frazier Life Sciences **$130M** With 10 others - **2025** 1 round - **Jun** **[Mosanna Therapeutics](https://millionrounds.com/company/mosanna-therapeutics)** Series A · CH · Silicon Canals **$80M** *Led* - **2024** 1 round - **May** **[Zenas BioPharma](https://millionrounds.com/company/zenas-biopharma)** Series C · US · Tellus BioVentures **$200M** With 14 others - **2021** 1 round - **Aug** **[Vigil Neuroscience](https://millionrounds.com/company/vigil-neuroscience)** Series B · US · Hatteras Venture Partners **$90M** With 12 others - **2019** 4 rounds - **Apr** **[Inozyme Pharma](https://millionrounds.com/company/inozyme-pharma)** Series A · US · FinSMEs **$67M** With 8 others - **Apr** **[Fusion Pharamaceuticals](https://millionrounds.com/company/fusion-pharamaceuticals)** Series B · CA · FinSMEs **$105M** With 11 others - **Mar** **[Karuna Therapeutics](https://millionrounds.com/company/karuna-therapeutics)** Series B · US · FinSMEs **$68M** With 8 others - **Feb** **[Bolt Biotherapeutics](https://millionrounds.com/company/bolt-biotherapeutics)** Series B · US · Prnewswire **$54M** *Led* - **2018** 1 round - **Jun** **[Sutro](https://millionrounds.com/company/sutro)** Series E · US · FinSMEs **$85M** With 17 others - **2017** 2 rounds - **Sept** **[Entasis Therapeutics](https://millionrounds.com/company/entasis-therapeutics)** Series B · US · FinSMEs **$32M** With 2 others - **May** **[Iterum Therapeutics](https://millionrounds.com/company/iterum-therapeutics)** Series B · IE · FinSMEs **$65M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **7 named** BK **Brian Kin Kwok Tse** Officer i Form ADV KH **Kin Ho Kwok** Director of general partner of general partner i Filing they signed ML **Michael Lawrence Travers** Corporate Counsel and Chief Operating Officer i Form ADV PT **Peter Tuxen Bisgaard** Director of the sole member of the General Partner i Filing they signed RT **Richard Tuxen Coles** Director of the sole member of the General Partner i Filing they signed RL **Robert Lorne Hopfner** Officer i Form ADV VS **Vincent Sai Sing Tuxen Cheung** Director of the sole member of the General Partner i Filing they signed We also hold **18** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$586M** gross assets of its funds Oct 2026 **Exempt** reporting adviser venture or small private funds - **Legal name:** Pivotal Bioventure Partners Investment Advisor LLC - **SEC number:** CRD 287988 ## What they claim to have backed From their own portfolio page (on their website) **0** of 1 we have independently watched raise 22fillmore Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. New fund on file **$1.1M** raised in Aug 2021 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Series B Series A Series C Median round joined **$80M** the round, not its cheque Alone, median **$54M** Led 2 of 11 rounds **18%** - **Sole investor:** 1 rounds - **Last cheque:** Jul 2026 Rounds by stage said on their site - Series B *7* - Series A *2* - Series C *1* - Series E *1* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Longitude Capital](https://millionrounds.com/fund/longitude-capital) 3 - [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 2 - [Eventide](https://millionrounds.com/fund/eventide) 2 - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 2 - [Norwest Venture Partners](https://millionrounds.com/fund/norwest) 2 - [Novo Holdings](https://millionrounds.com/fund/novo-ventures) 2 **Pitching Pivotal bioVenture Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Pivotal bioVenture Partners. A count of rooms they were both in, not a relationship either has claimed. [**Longitude Capital** VC firm **3** rounds together](https://millionrounds.com/fund/longitude-capital)[**Cormorant Asset Management** Private equity **2** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**Eventide** VC firm **2** rounds together](https://millionrounds.com/fund/eventide)[**New Enterprise Associates** VC firm **2** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Norwest Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/norwest)[**Novo Holdings** VC firm **2** rounds together](https://millionrounds.com/fund/novo-ventures)[**OrbiMed** Private equity **2** rounds together](https://millionrounds.com/fund/orbimed)[**Rock Springs Capital** Hedge fund **2** rounds together](https://millionrounds.com/fund/rock-springs-capital)[**SR One** Corporate VC **2** rounds together](https://millionrounds.com/fund/sr-one)[**Sofinnova Investments** VC firm **2** rounds together](https://millionrounds.com/fund/sofinnova-investments)[**TPG** Private equity **2** rounds together](https://millionrounds.com/fund/tpg)[**Wellington Management** VC firm **2** rounds together](https://millionrounds.com/fund/wellington-management) ## Recently backed The latest companies Pivotal bioVenture Partners put money into. [**Zenas BioPharma** $200M · May 2024](https://millionrounds.com/company/zenas-biopharma)[**Iterum Therapeutics** $65M · May 2017](https://millionrounds.com/company/iterum-therapeutics) ## Quick answers about Pivotal bioVenture Partners ### What does Pivotal bioVenture Partners invest in? Pivotal bioVenture Partners invests most often at Series B and Series A (82% of the rounds on record), in sectors such as Life Sciences, Therapeutics and Healthcare. ### How active is Pivotal bioVenture Partners? 11 investments on record, 1 of them in the last 12 months, and it led 2. The most recent was in Jul 2026. ### What has Pivotal bioVenture Partners invested in recently? Its most recent investments on record: Crystalys Therapeutics (Series B, Jul 2026), Mosanna Therapeutics (Series A, Jun 2025) and Zenas BioPharma (Series C, May 2024). ### How big are Pivotal bioVenture Partners's cheques? The median round it joins is $80M. ### Does Pivotal bioVenture Partners lead rounds? Yes: it led 2 of its 11 investments on record (18%). ### Where does Pivotal bioVenture Partners invest? Most of the companies it backs are in the United States (70%), Switzerland (10%) and Canada (10%). ### Is Pivotal bioVenture Partners investing now? Yes: it is actively investing, with 1 investments in the last 12 months. ### Who does Pivotal bioVenture Partners invest alongside? Most often Longitude Capital (3 rounds together), Cormorant Asset Management (2 rounds together) and Eventide (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=pivotal-life-sciences) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=pivotal-life-sciences)